Actively Recruiting
Ultrasound-Guided Platelet-Rich Plasma Injection Compared to Placebo for Thumb Base Osteoarthritis Treatment
Led by Goed Medisch Centrum · Updated on 2026-10-05
88
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether platelet-rich plasma PRP injections can reduce pain and improve function in adults with thumb base osteoarthritis CMC-I OA. This study compares PRP injections to placebo saline injections to understand their effects on pain, hand strength, thumb mobility, and any side effects. The study is a phase 2 randomized trial with double-blinding to ensure unbiased results. Participants will receive a single ultrasound-guided injection into the CMC-I joint, either 2 mL of PRP prepared from their own blood or 2 mL of saline as a placebo. The injection is given both inside the joint and around it, with no repeated injections. The placebo group also undergoes a blood draw to mimic the PRP preparation process without receiving PRP. During the 12-month follow-up, participants will attend visits at 3, 6, 9, and 12 months for clinical assessments. They will complete questionnaires about pain levels and hand function and undergo physical tests such as grip strength, pinch strength, and thumb motion measurements. Ultrasound evaluations will assess joint characteristics. Researchers will track pain improvement using a pain scale and monitor hand function and safety throughout the study.
CONDITIONS
Brief Title
Thumb Base Osteoarthritis: Ultrasound-guided Platelet-rich Plasma Versus Placebo Injection
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here